Bridgefront Capital’s Colgate-Palmolive CL Stock Holding History

Bridgefront Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,137	Closed	-$922K	–	654
2024 Q4	$922K	Buy	10,137 +4,790	+90%	+$457K	0.31%	76
2024 Q3	$555K	Buy	+5,347	New	+$545K	0.21%	158
2023 Q3	–	Sell	-9,132	Closed	-$704K	–	421
2023 Q2	$704K	Buy	+9,132	New	+$707K	0.38%	58
2022 Q4	–	Sell	-5,940	Closed	-$417K	–	381
2022 Q3	$417K	Buy	+5,940	New	+$466K	0.43%	65
2021 Q3	–	Sell	-13,931	Closed	-$1.13M	–	384
2021 Q2	$1.13M	Sell	13,931 -3,287	-19%	-$269K	0.43%	32
2021 Q1	$1.36M	Buy	+17,218	New	+$1.35M	0.42%	24

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Bridgefront Capital's CL Position: Q1 2025 in Review

Bridgefront Capital sold out of Colgate-Palmolive (CL) in Q1 2025, closing a stake of 10,137 shares — an estimated $922K sold.

Bridgefront Capital first reported a position in CL in Q1 2021 and held it in 6 quarters. The position peaked at $1.36M in Q1 2021. 1,942 funds tracked by Wall St. Rank hold CL as of Q1 2025.

Bridgefront Capital reported no remaining Colgate-Palmolive position as of Q1 2025 after selling out during the quarter.
Bridgefront Capital sold 10,137 Colgate-Palmolive shares in Q1 2025, an estimated $922K.
Bridgefront Capital first reported a position in Colgate-Palmolive in Q1 2021 and held it in 6 quarters.
Bridgefront Capital's Colgate-Palmolive position peaked at $1.36M in Q1 2021.
1,942 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Bridgefront Capital's 13F filing for Q1 2025, filed 15 May 2025.